Inpharamo will Facilitate Clinerion into Mexican Clinical Research Market

Inpharamo, a subsidiary of Semicrol, has signed a collaboration agreement to support the entry of the Swiss company, Clinerion. The partnership is dedicated to optimizing the identification of patients who are candidates for participation in clinical trials in Mexico.

For more information, click here.